DAJY

Wallstreetcn · Jan 25 at 11:15 PM

The A-share biopharmaceutical sector continues to strengthen, with Maccura, Hybribio Biotech, and KHB hitting the daily limit up in the afternoon. LIFERIVER and DAJY had previously reached their limit up, while WONDFO BIOTECH, ACROBIOSYSTEMS, Orient Biotech, and SSSW rose over 10%

Zhitong · Oct 30, 2025 at 03:50 AM

DAJY released its performance for the first three quarters, with a net loss attributable to the parent company of 142 million yuan

Zhitong · Oct 30, 2025 at 02:55 AM

DAJY: Authorized management to sell up to 3% of the company's total share capital

Zhitong · Sep 28, 2025 at 08:47 PM

DAJY's Kunjin virus nucleic acid detection kit launched in Guangdong

Zhitong · Sep 25, 2025 at 10:56 PM

DAJY: The nucleic acid detection kit for Chikungunya virus (fluorescent PCR method) has obtained the medical device registration certificate

Zhitong · Sep 8, 2025 at 04:37 AM

DAJY: Human Immunodeficiency Virus Type 1 (HIV-1) DNA test kit has obtained a medical device registration certificate